Cite
APA Citation
Willmann, S., Ince, I., Ahsman, M., Coboeken, K., Zhang, Y., Thelen, K., Kubitza, D., Zannikos, P., Zhou, W., Pina, L. M., Post, T., & Lippert, J. (2022). model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease. CPT: pharmacometrics & systems pharmacology, 11, 1111–1121. http://access.bl.uk/ark:/81055/vdc_100161799370.0x000007